Avance Biosciences

RNA Therapeutics Analysis & Characterization

Avance Biosciences brings seasoned GLP- and GMP-compliant assay development, assay validation, and testing services to the exploding world of RNA therapeutics. The development and production landscape for mRNA vaccines and other RNA-based therapeutics is busier than ever. The success of the mRNA COVID-19 vaccines has served as an important validation of the safety and efficacy of this approach and demonstrated the flexibility and speed with which an RNA drug can address an unmet need. Drug devel

GLP / GMP Protein Analysis Services

Avance Biosciences delivers robust and reliable immunoassay services to support the biologics development and approval process, from pre-clinical testing through manufacturing. The FDA, EMA, and other regulatory agencies require rigorous protein analysis, using validated assays, to ensure drug efficacy and safety. Our GLP- and GMP-compliant protein analysis services are built on sound science and regulatory expertise, so we can develop and validate the best immunoassays for your program, perform

CRISPR Edited Gene Testing

Avance Biosciences has more than two decades of experience providing advanced genomics services. As a true collaborative partner, we help you create a scientific and operational roadmap that helps you meet research, clinical, and commercial objectives. We’re ready and able to help you characterize your product’s off target site impact in detail, as well as navigate the evolving CRISPR gene editing standards laid out by the FDA and other regulatory bodies worldwide.